Stockbridge School of Agriculture, University of Massachusetts, Amherst, MA 01003.
Department of Plant, Soil, and Microbial Sciences, Michigan State University, East Lansing, MI 48824.
Plant Dis. 2018 Dec;102(12):2625-2631. doi: 10.1094/PDIS-12-17-2025-RE. Epub 2018 Oct 11.
Sclerotinia homoeocarpa isolates were collected from golf courses in Japan and the United States (2016-2017). Japan isolates were collected during a monitoring study and the U.S. isolates were collected due to field failure. Five succinate dehydrogenase inhibitor (SDHI) active ingredients (boscalid, fluopyram, fluxapyroxad, isofetamid, and penthiopyrad) were examined using in vitro sensitivity assays to determine cross-resistance. Sequence analysis revealed a point mutation leading to an amino acid substitution (H267Y) and a silent mutation (CTT to CTC) at codon 181 in the SdhB subunit gene. Isolates with the B-H267Y (n = 10) mutation were resistant to boscalid and penthiopyrad and had increased sensitivity to fluopyram. SdhB silent mutation 181C>T isolates (n = 2) were resistant to boscalid, isofetamid, and penthiopyrad. Sequence analysis revealed 3 mutations leading to an amino acid substitution (G91R, n = 5; G150R, n = 1; G159W, n = 1) in the SdhC subunit gene. Isolates harboring the SdhC (G91R or G150R) mutations were resistant to boscalid, fluxapyroxad, isofetamid, and penthiopyrad. A genetic transformation system was used to generate mutants from a SDHI sensitive isolate to confirm the B-H267Y and C-G91R mutations were direct determinants of SDHI resistance and associated with in vitro sensitivity assay results.
从日本和美国的高尔夫球场(2016-2017 年)采集到了 Sclerotinia homoeocarpa 分离株。日本的分离株是在监测研究中采集的,而美国的分离株是由于田间失败而采集的。使用体外敏感性测定法检查了 5 种琥珀酸脱氢酶抑制剂 (SDHI) 活性成分(咯菌腈、氟吡菌酰胺、氟唑菌酰胺、异噁唑草酮和戊唑醇),以确定交叉抗性。序列分析显示在 SdhB 亚基基因的密码子 181 处发生了一个点突变,导致一个氨基酸取代(H267Y)和一个沉默突变(CTT 到 CTC)。携带 B-H267Y(n = 10)突变的分离株对咯菌腈和戊唑醇具有抗性,并且对氟吡菌酰胺的敏感性增加。SdhB 沉默突变 181C>T 分离株(n = 2)对咯菌腈、异噁唑草酮和戊唑醇具有抗性。序列分析显示 3 个突变导致氨基酸取代(G91R,n = 5;G150R,n = 1;G159W,n = 1)在 SdhC 亚基基因中。携带 SdhC(G91R 或 G150R)突变的分离株对咯菌腈、氟唑菌酰胺、异噁唑草酮和戊唑醇具有抗性。使用遗传转化系统从 SDHI 敏感分离株中生成突变体,以确认 B-H267Y 和 C-G91R 突变是 SDHI 抗性的直接决定因素,并与体外敏感性测定结果相关。